9.45
price down icon5.97%   -0.60
after-market Dopo l'orario di chiusura: 9.45
loading

Passage Bio Inc Azioni (PASG) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
24.85%
5.814
7.737 - - -
Operating Income/Loss
37.21%
-10.33
-16.46 -14.27 -20.70 -17.38
Income/Loss From Continuing Operations Before Tax
39.08%
-9.385
-15.40 -12.72 -19.34 -15.99
Income/Loss From Continuing Operations After Tax
39.08%
-9.385
-15.40 -12.72 -19.34 -15.99
Net Income/Loss
39.08%
-9.385
-15.40 -12.72 -19.34 -15.99
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
94.90%
3.1689
62.11 0.4845 61.76 61.68
Diluted Average Shares
94.90%
3.1689
62.11 0.4845 61.76 61.68
Basic Earnings Per Share
1,084%
-2.96
-0.25 -0.20 -0.31 -0.26
Diluted Earnings Per Share
1,084%
-2.96
-0.25 -0.20 -0.31 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.38
price down icon 0.39%
$97.03
price down icon 1.63%
$31.35
price down icon 0.70%
$92.23
price down icon 1.68%
biotechnology ONC
$304.31
price down icon 2.05%
$200.67
price up icon 1.90%
Capitalizzazione:     |  Volume (24 ore):